Evidence map›Paper›PMID 35008593›Full record

ArticleInternational journal of molecular sciences2021

A Glance into MTHFR Deficiency at a Molecular Level.

Castrense Savojardo, Giulia Babbi, Davide Baldazzi, Pier Luigi Martelli, Rita Casadio

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Molecular Effects of Mutations in Human Genetic Diseases.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Castrense SavojardoBiocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-7359-0633
Giulia BabbiBiocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-9816-4737
Davide BaldazziBiocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
Pier Luigi MartelliBiocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-0274-5669
Rita CasadioBiocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-7462-7039
University of Bologna · ITInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca PRIN project 2017483NH8
6 · The paper itself

Abstract

MTHFR deficiency still deserves an investigation to associate the phenotype to protein structure variations. To this aim, considering the MTHFR wild type protein structure, with a catalytic and a regulatory domain and taking advantage of state-of-the-art computational tools, we explore the properties of 72 missense variations known to be disease associated. By computing the thermodynamic ΔΔG change according to a consensus method that we recently introduced, we find that 61% of the disease-related variations destabilize the protein, are present both in the catalytic and regulatory domain and correspond to known biochemical deficiencies. The propensity of solvent accessible residues to be involved in protein-protein interaction sites indicates that most of the interacting residues are located in the regulatory domain, and that only three of them, located at the interface of the functional protein homodimer, are both disease-related and destabilizing. Finally, we compute the protein architecture with Hidden Markov Models, one from Pfam for the catalytic domain and the second computed in house for the regulatory domain. We show that patterns of disease-associated, physicochemical variation types, both in the catalytic and regulatory domains, are unique for the MTHFR deficiency when mapped into the protein architecture.

Indexed as

Catalytic DomainHomocystinuriaHumansMethylenetetrahydrofolate Reductase (NADPH2)Muscle SpasticityProtein Interaction MapsPsychotic DisordersMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanconsensus methoddisease HMM modelsdisease related variationsfunctional annotationMTHFR deficiencyMTHFR variantsprotein-protein interactionssolvent accessibilitystructural annotationΔΔG predictions

Identifiers

PMID35008593
PMCPMC8745156
OpenAlexW4200015945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.